Literature DB >> 31124198

Characterization of Effect of Repeated Bolus or Continuous Intrathecal Infusion of Morphine on Spinal Mass Formation in the Dog.

Keith R Hildebrand1, Linda M Page1, Tina M Billstrom2, Joanne J Steinauer3, Kelly A Eddinger3, Shervin Arjomand3, Tony L Yaksh3.   

Abstract

BACKGROUND: We determined whether intrathecally delivering the same daily dose of morphine (MS) at a fixed concentration of 25 mg/mL by periodic boluses versus continuous infusion would reduce intrathecal mass (IMs) formation in dogs.
METHODS: Adult dogs (hound cross, n = 32) were implanted with intrathecal catheters connected to SynchroMed II infusion pumps. Animals were randomly assigned to receive infusion of 0.48 mL/day of saline or MS dosing (12 mg/day at 25 mg/mL) as boluses: x1 (q24hour), x2 (q12hour), x4 (q6hour), or x8 (q3hour) given at the rate of 1000 μL/hour, or as a continuous infusion (25 mg/mL/20 μL/hour).
RESULTS: With IT saline, minimal pathology was noted. In contrast, animals receiving morphine displayed spinally compressing durally derived masses with the maximal cross-sectional area being greatest near the catheter tip. Histopathology showed that IMs consisted of fibroblasts in a collagen (type 1) matrix comprised of newly formed collagen near the catheter and mature collagen on the periphery of the mass. The rank order of median cross-sectional mass area (mm2 ) was: Saline: 0.7 mm2 ; x2: 1.8 mm2 ; x4: 2.7 mm2 ; x1: 2.7 mm2 ; x8: 4.2 mm2 ; Continuous: 8.1 mm2 , with statistical difference from saline being seen with continuous (p < 0.0001) and x8 (p < 0.05). Bench studies with a 2D diffusion chamber confirmed an increase in dye distribution and lower peak concentrations after bolus delivery versus continuous infusion of dye.
CONCLUSIONS: Using multiple bolus dosing, IMs were reduced as compared to continuous infusion, suggesting relevance of bolus delivery in yielding reduced intrathecal masses.
© 2019 International Neuromodulation Society.

Entities:  

Keywords:  Bolus delivery; intrathecal drug; intrathecal granuloma; intrathecal pump; morphine

Mesh:

Substances:

Year:  2019        PMID: 31124198      PMCID: PMC6803019          DOI: 10.1111/ner.12963

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  42 in total

1.  Chronically infused intrathecal morphine in dogs.

Authors:  Tony L Yaksh; Kjersti A Horais; Nicolle A Tozier; Jeffrey W Allen; Michael Rathbun; Steven S Rossi; Claudia Sommer; Carol Meschter; Philip J Richter; Keith R Hildebrand
Journal:  Anesthesiology       Date:  2003-07       Impact factor: 7.892

2.  Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion.

Authors:  H W Heetla; M J Staal; T van Laar
Journal:  Spinal Cord       Date:  2009-11-17       Impact factor: 2.772

3.  Intrathecal Catheterization and Drug Delivery in Guinea Pigs: A Small-animal Model for Morphine-evoked Granuloma Formation.

Authors:  Kelly A Eddinger; Eric S Rondon; Veronica I Shubayev; Marjorie R Grafe; Miriam Scadeng; Keith R Hildebrand; Linda M Page; Shelle A Malkmus; Joanne J Steinauer; Tony L Yaksh
Journal:  Anesthesiology       Date:  2016-08       Impact factor: 7.892

4.  Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular.

Authors:  Armaghan Emami; Jeff Tepper; Brian Short; Tony L Yaksh; Alison M Bendele; Thulasi Ramani; Alvaro F Cisternas; Jay H Chang; R Daniel Mellon
Journal:  Int J Toxicol       Date:  2017-12-21       Impact factor: 2.032

Review 5.  Emerging Roles for MAS-Related G Protein-Coupled Receptor-X2 in Host Defense Peptide, Opioid, and Neuropeptide-Mediated Inflammatory Reactions.

Authors:  Hydar Ali
Journal:  Adv Immunol       Date:  2017-07-24       Impact factor: 5.324

6.  Complex dosing schedules for continuous intrathecal baclofen infusion.

Authors:  Linda E Krach; Robert L Kriel; Andrea C Nugent
Journal:  Pediatr Neurol       Date:  2007-11       Impact factor: 3.372

7.  Pharmacokinetic aspects of intrathecal morphine analgesia.

Authors:  G Nordberg; T Hedner; T Mellstrand; B Dahlström
Journal:  Anesthesiology       Date:  1984-05       Impact factor: 7.892

8.  Pharmacokinetics of intrathecal morphine and meperidine in humans.

Authors:  S Sjöström; A Tamsen; M P Persson; P Hartvig
Journal:  Anesthesiology       Date:  1987-12       Impact factor: 7.892

Review 9.  Best Practices for Intrathecal Baclofen Therapy: Dosing and Long-Term Management.

Authors:  Aaron L Boster; Roy L Adair; Judith L Gooch; Mary Elizabeth S Nelson; Andrea Toomer; Joe Urquidez; Michael Saulino
Journal:  Neuromodulation       Date:  2016-07-19

10.  Alfentanil: correlations between absence of effect upon subcutaneous mast cells and absence of granuloma formation after intrathecal infusion in the dog.

Authors:  Tony L Yaksh; Joanne J Steinauer; Samantha L Veesart; Shelle A Malkmus
Journal:  Neuromodulation       Date:  2012-11-21
View more
  1 in total

Review 1.  Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient.

Authors:  Jose De Andres; Salim Hayek; Christophe Perruchoud; Melinda M Lawrence; Miguel Angel Reina; Carmen De Andres-Serrano; Ruben Rubio-Haro; Mathew Hunt; Tony L Yaksh
Journal:  Front Pain Res (Lausanne)       Date:  2022-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.